THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS

Download Report

Transcript THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS

THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS

A DUTCH POPULATION BASED STUDY

Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der Graaf Medical Oncology, Radboud University Medical Centre, Nijmegen

Literature

Literature

Research question

• Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients?

Research question

• Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients?

• Do treatment modalities explain the differences between variant age groups?

Materials & Methods

• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records

Materials & Methods

• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records • Cancer care in the Netherlands • Sarcoma care centralised in recent years

Materials & Methods

• The Netherlands Cancer Registry: • >95% coverage • Information at diagnosis • • Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records • Cancer care in the Netherlands • Sarcoma care centralised in recent years • Statistics: • • • • Kaplan Meier for Overall survival (OS) Relative survival (RS) Univariate analyses Multivariate Cox regression analyses

Age groups Children

< 18years

Adults

35-64years

AYAs

18-34years

Elderly

≥65years

Patient cohort Patients histologically diagnosed with SS: 1989-2012

102 (17%) 46 (8%) 438 (75%) Localized disease Metastatic disease Unknown Total: 586 patients

Overall survival: stage at diagnosis

• Median follow up: 42 months (range 0-300 months) No metastasis 5yr OS: 64±2% Unknown stage Metastases median survival: 11±1months

Survival time (months)

Localised disease

Patient characteristics Variable

Age Sex Histology Hospital of surgery o o o o o o o o o o o o <18 years 18-34 years 35-64 years ≥65 years Male Female Monophasic Biphasic

Not specified

General hospital Academic hospital

Unknown

n = 438

51 143 192 52 236 202 95 98 245 108 196 134

(100%)

(12%) (33%) (44%) (12%) (54%) (46%) (22%) (22%) (56%) (25%) (45%) (31%)

Patient characteristics Variable

Site of origin Therapy Resection status o o o o o o o o o o o Extremities Head and neck Trunk Other Surgery alone Surgery + RT (+CT) Surgery + CT No surgery R0 R1 / R2

R status unknown

n = 438

294 36 78 30 151 206 38 43 135 51 252

(100%)

(67%) (8%) (18%) (7%) (35%) (47%) (9%) (10%) (31%) (12%) (58%)

Overall survival: age groups

5yr OS: 91±4% Children 5yr OS: 72±4% 5yr OS: 57±4% 5yr OS: 43±7% AYAs Adults Elderly

Survival time (months)

Relative survival: age groups

5yr OS: 91%

5yr RS: 91%

5yr OS: 72%

5yr RS: 72%

5yr OS: 57%

5yr RS: 58%

5yr OS: 43%

5yr RS: 53%

Children AYAs Adults Elderly RS: Corrected for age, sex and year

Age as a continous variable Age (years)

Cox regression: Univariate analyses Variables

Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status

Cox regression: Univariate analyses Variables

Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10

Cox regression: Univariate analyses Variables

Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10

Cox regression: Univariate analyses Variables

Age groups Sex Histology Hospital of surgery Site of origin Therapy Resection status p < 0.10

Treatment modalities

*Chi-square: p<0.05

* 100% Surgery + CT 80% 60% 40% 20% 0% Surgery + RT (+CT) Surgery alone Total Children AYAs Adults Elderly 43 patients received no surgery  left out of multivariate analysis

Cox regression: Multivariate analysis Age groups

Children AYAs Adults Elderly

Treatment

Surgery alone Surgery + (neo)adj radiotherapy* Surgery + (neo)adj chemotherapy

Primary localisation

Extremities Head and neck Trunk Other 0,1 1,0 10,0 49 1 136 2.26

171 3.81

39 6.52

151 1 206 0.93

38 1.75

n HR 279 1 33 1.05

60 1.97

23 2.04

Cox regression: Multivariate analysis Age groups

Children AYAs Adults Elderly

Treatment

Surgery alone Surgery + RT (+CT) Surgery + CT

Primary localisation

Extremities Head and neck Trunk Other 0,1 1,0 10,0 49 1 136 2.26

171 3.81

39 6.52

n HR 151 1 206 0.93

38 1.75

279 1 33 1.05

60 1.97

23 2.04

Cox regression: Multivariate analysis

n HR

Age groups

Children AYAs Adults Elderly 49 1 136 2.26

171 3.81

39 6.52

Treatment

Surgery alone Surgery + RT (+CT) Surgery + CT

Primary localisation

Extremities Head and neck Trunk Other 151 1 206 0.93

38 1.75

279 1 33 1.05

60 1.97

23 2.04

0,1 1,0 10,0

Take home messages

1.

Age at diagnosis is an independent prognostic factor for overall and relative survival 2.

Survival differences can not be explained by treatment modalities

Future research

• Further research in tumor biology is necessary to explain the survival differences